Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
3.650
+0.310 (9.28%)
At close: Aug 19, 2026, 4:00 PM EDT
3.620
-0.030 (-0.82%)
Pre-market: Aug 20, 2026, 8:48 AM EDT
Rocket Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, Rocket Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $8.84. The average 1-year stock price forecast is 142.19% higher than the current stock price, while the lowest is $3.00 (-17.81%) and the highest is $15 (+310.96%).
Price Target: $8.84 (+142.19%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Rocket Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 6 | 6 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 6 | 6 | 6 | 6 | 6 | 6 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 14 | 14 | 14 | 14 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $10 | Buy | Maintains | $10 | +173.97% | Aug 12, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Reiterates $5 | Hold | Reiterates | $5 | +36.99% | Aug 11, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $15 | Buy | Reiterates | $15 | +310.96% | Aug 11, 2026 |
| Wedbush | Wedbush | Buy Reiterates $16 → $15 | Buy | Reiterates | $16 → $15 | +310.96% | Aug 11, 2026 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Aug 11, 2026 |
Financial Forecast
Revenue This Year
1.11M
Revenue Next Year
11.46M
from 1.11M
Increased by 935.17%
EPS This Year
-0.11
from -1.98
EPS Next Year
-1.30
from -0.11
EPS and Forward PE are based on non-GAAP adjusted numbers.